Health Canada drug identification number

DIN 02453304 — RAVICTI 1.1 G

RAVICTI is a liquid of Glycerol phenylbutyrate marketed by HORIZON THERAPEUTICS IRELAND DAC. The full Glycerol phenylbutyrate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02453304
Brand name
RAVICTI
Active ingredient
Glycerol phenylbutyrate
Strength
1.1 G
Dosage form
LIQUID
Route
ORAL
Manufacturer
HORIZON THERAPEUTICS IRELAND DAC
Health Canada status
MARKETED
Drug class
Nitrogen-binding agent (ammonia-scavenging agent for urea cycle disorders)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.